PRE 14C

PRELIMINARY INFORMATION STATEMENT SCHEDULE 14C

Company: Theriva Biologics, Inc.
Filed: September 8, 2005
Period of Report: September 8, 2005
Accession Number: 0001295345-05-000024

View Document ↗ View on SEC.gov ↗